Evidence map›Paper›PMID 32418724›Full record

ReviewTrends in molecular medicine2020

Emergence of New Disease: How Can Artificial Intelligence Help?

Yurim Park, Daniel Casey, Indra Joshi, Jiming Zhu, Feng Cheng

Abstract readReview
In one paragraph

Review in Trends in molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. AI in Fighting Covid-19: Pandemic Management.Procedia computer science · 2021
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yurim ParkRadcliffe Department of Medicine, Medical Sciences Division, University of Oxford, Oxford, UK. Electronic address: yurim.park@st-hugh.ox.ac.uk.
Daniel CaseyInnovation Faculty, Celltrion Healthcare, Slough, UK.
Indra JoshiDigital Health and Artificial Intelligence Laboratory, National Health Service, London, UK.
Jiming ZhuVanke School of Public Health and School of Medicine, Tsinghua University, Beijing, China; Institute for Hospital Management, Tsinghua Shenzhen International Graduate School, Shenzhen, China.
Feng ChengVanke School of Public Health and School of Medicine, Tsinghua University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emergence of new disease remains a critical parameter in human health and society. Advances in artificial intelligence (AI) allow for rapid processing and analysis of massive and complex data. In this forum article, the recent applications across disease prediction and drug development in relation to the COVID-19 pandemic are reviewed.

Indexed as

Artificial IntelligenceBetacoronavirusCommunicable Diseases, EmergingCoronavirus InfectionsCOVID-19HumansMachine LearningPandemicsPneumonia, ViralSARS-CoV-2artificial IntelligenceCOVID-19machine learning

Identifiers

PMID32418724
PMCPMC7196393

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.